HINGE HEALTH INC-A (HNGE) Stock Analyst Ratings
USA • New York Stock Exchange • NYSE:HNGE • US4333131039
34.625 USD
-1.59 (-4.4%)
Last: Jan 30, 2026, 10:25 AM
ChartMill assigns a Buy % Consensus number of 83% to HNGE. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 64.6. This target is 86.57% above the current price.
- HNGE was analyzed by 21 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about HNGE.
- In the previous month the buy percentage consensus was at a similar level.
- HNGE was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-23 | Freedom Capital Markets | Initiate | Buy |
| 2026-01-09 | Wells Fargo | Initiate | Overweight |
| 2026-01-09 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-01-08 | Keybanc | Maintains | Overweight -> Overweight |
| 2026-01-06 | Needham | Reiterate | Buy -> Buy |
| 2026-01-05 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-05 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-05 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-11-05 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-10-08 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-09-23 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-09-11 | Stifel | Maintains | Buy -> Buy |
| 2025-09-05 | Baird | Initiate | Neutral |
| 2025-08-06 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-08-06 | Needham | Maintains | Buy -> Buy |
| 2025-08-06 | Barclays | Maintains | Overweight -> Overweight |
| 2025-08-06 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-08-06 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-06 | B of A Securities | Maintains | Buy -> Buy |
| 2025-08-06 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-08-01 | Stifel | Maintains | Buy -> Buy |
| 2025-07-14 | JMP Securities | Initiate | Market Outperform |
| 2025-07-14 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-07-14 | Barclays | Maintains | Overweight -> Overweight |
| 2025-06-16 | William Blair | Initiate | Outperform |
| 2025-06-16 | Needham | Initiate | Buy |
| 2025-06-16 | Keybanc | Initiate | Overweight |
| 2025-06-16 | RBC Capital | Initiate | Outperform |
| 2025-06-16 | Stifel | Initiate | Buy |
| 2025-06-16 | Barclays | Initiate | Overweight |
HINGE HEALTH INC-A / HNGE FAQ
What is the price target for HNGE stock?
21 analysts have analysed HNGE and the average price target is 64.6 USD. This implies a price increase of 86.57% is expected in the next year compared to the current price of 34.625.
What is the consensus rating for HINGE HEALTH INC-A (HNGE) stock?
The consensus rating for HINGE HEALTH INC-A (HNGE) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover HINGE HEALTH INC-A (HNGE) stock?
The number of analysts covering HINGE HEALTH INC-A (HNGE) is 21.